ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
92.33
-3.47 (-3.62%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close95.80
Open95.57
Bid0.00 x 900
Ask0.00 x 2200
Day's Range92.11 - 95.80
52 Week Range66.93 - 101.73
Volume31,612,912
Avg. Volume5,148,223
Market Cap52.037B
Beta (3Y Monthly)0.94
PE Ratio (TTM)10.69
EPS (TTM)8.64
Earnings DateFeb 25, 2019 - Mar 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2003-11-12
1y Target Est92.56
Trade prices are not sourced from all markets
  • Moody's15 days ago

    Express Scripts Holding Company -- Moody's confirms Express Scripts at Baa2; stable outlook

    This concludes a rating review initiated on March 9, 2018 following the announcement that Cigna Corporation ("Cigna") reached a definitive agreement to acquire Express Scripts in a transaction valued at approximately $67 billion. Moody's changed the direction of the rating review from uncertain to downgrade on September 6, 2018.

  • Benzinga15 days ago

    Analysts: Cigna Offers Earnings Growth Potential, But Faces Legal Risks Tied To Aborted Anthem Deal

    Cigna Holding Co (NYSE: CI) recently completed its acquisition of pharmacy benefit manager Express Scripts. Raymond James analyst John Ransom upgraded Cigna from Market Perform to Outperform with a $215 price target. Wells Fargo Securities analyst Peter Costa maintained a Market Perform rating for Cigna and lowered the price target from $221 to $200.

  • GuruFocus.com15 days ago

    5 Health Care Stocks Gurus Are Buying

    Gilead on the list

  • 5 Great Healthcare Stocks to Buy for 2019
    Zacks23 days ago

    5 Great Healthcare Stocks to Buy for 2019

    Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.

  • 'Good for the region': Express Scripts CEO on what's next after the $54 billion Cigna buyout
    American City Business Journals28 days ago

    'Good for the region': Express Scripts CEO on what's next after the $54 billion Cigna buyout

    Express Scripts CEO Tim Wentworth on Thursday sought to calm fears that the company's $54 billion acquisition by insurer Cigna would negatively impact St. Louis.

  • Moody's29 days ago

    Connecticut General Life Insurance Company -- Moody's downgrades Cigna's long-term ratings (senior unsecured debt to Baa2); outlook stable

    Moody's Investors Service has downgraded Cigna Corporation's long-term ratings, including its senior unsecured debt rating to Baa2 from Baa1, upon the closing of its acquisition of Express Scripts Holding Company (ESI, Baa2, Review Down). Total senior unsecured debt of approximately $41 billion includes $20 billion issued by subsidiary Halfmoon Parent, Inc. (now known as Cigna Corporation), legacy Cigna Corporation (now known as Cigna Holding Company) debt of approximately $5.3 billion and legacy ESI debt of approximately $12.8 billion.

  • The Wall Street Journal29 days ago

    [$$] Cigna and Express Scripts Seal $54 Billion Merger

    Cigna Corp. completed its $54 billion acquisition of Express Scripts Holding Co., setting up a battle among giant health companies to try to cut health-care costs by managing both medical and drug benefits. The Cigna deal, which won an antitrust nod from the Justice Department without requiring divestitures, brings together a health insurer with a strong focus on employers with a major pharmacy-benefit manager. In an interview, Cigna Chief Executive David Cordani said an initial focus of the combined company will be on ensuring continued smooth business-as-usual operations, but it will begin rolling out new initiatives next year that seek to take advantage of the tie-up between medical and pharmacy oversight, including efforts focused on specialty pharmaceuticals and mental health.

  • Reuters29 days ago

    Cigna closes $54 billion purchase of Express Scripts

    Cigna Corp (CI.N) on Thursday closed its $54-billion (42.65 billion pounds) deal to buy Express Scripts Holding Co, creating one of the biggest providers of pharmacy benefits and insurance plans in the United States, a combination it says will help it improve healthcare coordination and cut costs. Cigna's deal puts it in direct competition with two other healthcare companies set up the same way - Aetna with CVS Health Corp (CVS.N) and UnitedHealth Group Inc (UNH.N) with Optum. Cigna's deal has already passed antitrust scrutiny.

  • Express Scripts, Cigna finalize $54 billion merger
    American City Business Journals29 days ago

    Express Scripts, Cigna finalize $54 billion merger

    Cigna closed on its acquisition of north St. Louis County-based Express Scripts Thursday after receiving final regulatory approval for the $54 billion deal on Wednesday.

  • Reuters29 days ago

    Cigna closes $54 billion purchase of Express Scripts

    Cigna Corp on Thursday closed its $54-billion deal to buy Express Scripts Holding Co, creating one of the biggest providers of pharmacy benefits and insurance plans in the United States, a combination it says will help it improve healthcare coordination and cut costs. Cigna's deal puts it in direct competition with two other healthcare companies set up the same way - Aetna with CVS Health Corp and UnitedHealth Group Inc with Optum. Cigna's deal has already passed antitrust scrutiny.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit29 days ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    This could indicate that investors who seek to profit from falling equity prices are not currently targeting ESRX. Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • MarketWatchlast month

    Celanese stock rises on inclusion to S&P 500

    Celanese Corp. shares rose in the extended session Wednesday after S&P Dow Jones Indices said the specialty chemical company would be joining the S&P 500 index . Celanese shares rose 4.8% after hours, following a 0.7% decline to close the regular session at $84.77. S&P said Celanese will trade on the index before the market opens on Monday, replacing Express Scripts Holding Co. which is being acquired by Cigna Corp.

  • PR Newswirelast month

    Celanese Set to Join S&P 500

    NEW YORK , Dec. 19, 2018 /PRNewswire/ -- Celanese Corp. (NYSE: CE) will replace Express Scripts Holding Co. (NASD: ESRX) in the S&P 500 effective prior to the open of trading on Monday, December 24 . S&P ...

  • Final state approves $54 billion Express Scripts, Cigna merger
    American City Business Journalslast month

    Final state approves $54 billion Express Scripts, Cigna merger

    On Tuesday, regulators from New Jersey approved the deal, according to a Securities and Exchange (SEC) filing Wednesday. Both Cigna and Express Scripts said they expect to close the transaction Thursday now that all regulatory approvals have been received. Although the combined company will be headquartered in Bloomfield, Connecticut, the Express Scripts headquarters is expected to remain in St. Louis, with Tim Wentworth, president and CEO of the organization, leading the unit.

  • ACCESSWIRElast month

    Today's Research Reports on Trending Tickers: Centene and Express Scripts Holding

    NEW YORK, NY / ACCESSWIRE / December 18, 2018 / U.S. equities extended losses on Monday as investors await details from the Federal Reserve's final policy meeting of 2018 on Wednesday. The Dow Jones Industrial ...

  • Zackslast month

    Here's Why You Should Buy Express Scripts (ESRX) Stock Now

    Strong demand for Express Scripts' (ESRX) solutions like SafeGuardRx, 90-day supply for chronic medications, exclusive Accredo Specialty Pharmacy and advanced opioid solutions buoy optimism.

  • Argentiere Capital’s Returns, AUM and Holdings
    Insider Monkeylast month

    Argentiere Capital’s Returns, AUM and Holdings

    Deepak Gulati‘s Argentiere Capital is a Zug, Switzerland-based hedge fund launched back in June 2013, with an additional office in Chicago. The fund is focused on offering its services to pooled investment vehicles and manages separate client-focused equity portfolios. It’s run by a team of former members of JP Morgan’s Global Equities Proprietary Trading Group […]

  • Only one state stands in the way of $54B Cigna/Express Scripts deal
    American City Business Journalslast month

    Only one state stands in the way of $54B Cigna/Express Scripts deal

    Only one state stands in the way of approving the $54 billion merger between Cigna and Express Scripts after government authorities in California and New York signed off on the deal Thursday. Both California's Department of Managed Health Care and New York's Department of Financial Services approved the deal and listed a set of conditions the companies agreed to. Conditions to the transaction in California Conditions to the transaction in New York Per the California approval, Cigna and Express Scripts agree to not increase premiums as a result of acquisition costs, and keep premium rate increases to a minimum.

  • Is Express Scripts Holding (ESRX) Stock Outpacing Its Medical Peers This Year?
    Zackslast month

    Is Express Scripts Holding (ESRX) Stock Outpacing Its Medical Peers This Year?

    Is (ESRX) Outperforming Other Medical Stocks This Year?

  • Zackslast month

    Express Scripts Announces 3-Year Agreement With Walmart

    Express Scripts (ESRX) and Walmart (WMT) collaborate to increase affordable access of the expensive prescription drugs for insured and uninsured patients.

  • Dealmaker Patrick Nolan on St. Louis’ big year in M&A
    American City Business Journalslast month

    Dealmaker Patrick Nolan on St. Louis’ big year in M&A

    St. Louis has had a blockbuster year in mergers and acquisitions, though two big company headquarters — Monsanto Co. and Express Scripts Holding Co. — are being lost in the process.

  • The Wall Street Journallast month

    [$$] Walmart, Express Scripts Extend Prescription-Services Agreement

    Retail giant Walmart Inc. and pharmacy-benefit manager Express Scripts Holding Co. have extended their network agreement to provide access to Walmart’s prescription services for Express Scripts clients’ covered members. The three-year agreement will help both insured and uninsured customers save money on prescription drugs, the companies said Wednesday. Walmart also will participate in Express Scripts’s pharmacy-savings program called InsideRx, which provides discounts, on average of 40%, to uninsured Americans using brand-name prescription drugs.

  • Walmart & Express Scripts extend deal, McDonald's serves up changes, CBS settles lawsuit
    Yahoo Financelast month

    Walmart & Express Scripts extend deal, McDonald's serves up changes, CBS settles lawsuit

    Walmart, McDonald's, CBS, Credit Suisse and Dave & Buster's are the companies to watch.

  • MarketWatchlast month

    Walmart and Express Scripts to offer cheaper meds to uninsured and underinsured Americans

    Shares of Walmart Inc. and Express Scripts Holding Co. rose in premarket trade Wednesday, after the two announced a three-year agreement to provide cheaper medications to underinsured and uninsured Americans. Walmart will have access to Express Scripts' lower pricing on dozens of brand-name prescription drugs. The pharmacy benefits manager will offer its InsideRx, which provides discounts of an average of 40% to uninsured customers on brand-name prescription drugs. Express Scripts shares rose 1.2% premarket and have gained 29% in 2018, while the S&P 500 has fallen 1.4%.

  • PR Newswirelast month

    Walmart and Express Scripts Sign Three-Year Agreement to Deliver Greater Value to Insured and Uninsured Pharmacy Customers

    BENTONVILLE, Ark. and ST. LOUIS, Dec. 12, 2018 /PRNewswire/ -- Today, Walmart and Express Scripts (ESRX) announced an extension to the companies' existing network agreement to provide access to Walmart's prescription services for Express Scripts clients' covered members.  The companies also made a commitment to deliver additional affordable prescription solutions to millions of underinsured and uninsured Americans. As part of the ongoing relationship, Walmart is partnering with Express Scripts' to access their unique pricing on dozens of brand-name prescription drugs, and create additional value for its customers. As one example, Express Scripts has introduced a novel solution – InsideRx -- to provide discounts, on average 40%, to uninsured Americans on a growing number of important brand-name prescription drugs.